Abrogation of b16 melanoma metastases by long-term low-dose interleukin-6 therapy
Anne Katz, Lester M. Shulman, Angel Porgador, Michel Revel, Michael Feldman, Lea Eisenbach
Research output: Contribution to journal › Article › peer-review
35Scopus
citations
Fingerprint
Dive into the research topics of 'Abrogation of b16 melanoma metastases by long-term low-dose interleukin-6 therapy'. Together they form a unique fingerprint.